[{"NetIncomeLoss_1_Q2_USD":-35389000.0,"OperatingLeaseLiability_0_Q2_USD":2828000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":455000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":11880000.0,"PaymentsToAcquireShortTermInvestments_2_Q2_USD":362469000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":21000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-132187000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":4000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":851000.0,"AssetsCurrent_0_Q2_USD":378454000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":79000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":29983000.0,"FinanceLeaseLiabilityNoncurrent_0_Q2_USD":2258000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":141000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":137000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":4824659.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":5336294.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":383000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":834000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":-28000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":79000.0,"CommonStockSharesIssued_0_Q2_shares":50226739.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":298815000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":15465000.0,"Liabilities_0_Q2_USD":36701000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":69339000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":114000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":404000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":45015000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":25104000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":3409000.0,"EarningsPerShareBasic_2_Q2_USD":0.17,"EarningsPerShareBasic_1_Q2_USD":-0.7,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":454000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":49644704.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":50209484.0,"ProceedsFromStockPlans_2_Q2_USD":388000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":16984000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-5022000.0,"NumberOfReportableSegments_2_Q2_segment":1.0,"CommonStockValue_0_Q2_USD":50000.0,"OtherNonoperatingIncome_2_Q2_USD":100000000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-598000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":518000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":165968000.0,"CostsAndExpenses_2_Q2_USD":75139000.0,"CostsAndExpenses_1_Q2_USD":40706000.0,"RestrictedCash_0_Q2_USD":328000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":368154000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":8333000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-35310000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":114000.0,"Assets_0_Q2_USD":388390000.0,"ShareBasedCompensation_2_Q2_USD":10860000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":1671000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"EarningsPerShareDiluted_1_Q2_USD":-0.7,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":455000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":455000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":25000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":5669000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-65371000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":48931127.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":50209484.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":818000.0,"LiabilitiesCurrent_0_Q2_USD":17459000.0,"AccountsPayableCurrent_0_Q2_USD":5009000.0,"NonoperatingIncomeExpense_2_Q2_USD":100175000.0,"NonoperatingIncomeExpense_1_Q2_USD":21000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":10300000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":3849000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":341000.0,"AdditionalPaidInCapital_0_Q2_USD":802584000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":69667000.0,"LesseeOperatingLeaseDiscountRate_0_Q2_pure":0.1,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":4886000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":16984000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":3051000.0,"NetIncomeLoss_2_Q2_USD":8361000.0,"EarningsPerShareDiluted_2_Q2_USD":0.17,"ShortTermInvestments_0_Q2_USD":298815000.0,"CommonStockSharesOutstanding_0_Q2_shares":50226739.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-450966000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":161731000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":581000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":502000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":1374000.0,"CommonStockSharesAuthorized_0_Q2_shares":120000000.0,"OperatingIncomeLoss_2_Q2_USD":-74830000.0,"OperatingIncomeLoss_1_Q2_USD":-40432000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":25345000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":-40411000.0,"InvestmentIncomeInterest_2_Q2_USD":175000.0,"InvestmentIncomeInterest_1_Q2_USD":21000.0,"PreferredStockValue_0_Q2_USD":null,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":16984000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":388390000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":570000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":228000.0,"ProfitLoss_2_Q2_USD":8361000.0,"StockholdersEquity_0_Q2_USD":351689000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":260000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":298794000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_2_Q2_USD":135542000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":274000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":309000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-31590000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":1688000.0,"Ticker":"RYTM","CIK":"1649904","name":"RHYTHM PHARMACEUTICALS, INC.","OfficialName":"Rhythm Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"415723429.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210803"}]